HanchorBio dedicates to develop biological medicines with simultaneous multi-targeting through a novel IgG Fc-Based Designer Biologics (FBDB™) platform.

HanchorBio

CULTURE

The culture of emphasis on innovation, quality, and speed will remain and be nourished

VISION

To be a pioneering biotech company that transforms innovative drug development with biologics having novel modalities.

MISSION

MISSION To transcend the Immuno-Oncology therapeutics by developing cutting-edge designer biologics with innovative modalities for cancer patients.

CORE VALUES

INNOVATION

INTEGRITY

EXECUTION

EXCELLENCE

ACCOUNTABILITY

TEAM WORK

LEADERSHIP TEAM

SCOTT LIU, PH.D.

SCOTT LIU, PH.D.

Founder, Chairman & CEO of HanchorBio

Founder, Chairman & CEO of HanchorBio

SEAN JUO, PH.D.

SEAN JUO, PH.D.

General Manager & Chief Scientific Officer

General Manager & Chief Scientific Officer

Yuehua Cong, Ph.D.

Yuehua Cong, Ph.D.

Chief Business Officer

Chief Business Officer

Jason Tsai, M.D., M.S.

Jason Tsai, M.D., M.S.

Chief Medical Officer

Chief Medical Officer

CHI-LING TSENG, PH.D.

CHI-LING TSENG, PH.D.

VP of Research

VP of Research

WEIDONG JIANG, PH.D.

WEIDONG JIANG, PH.D.

Director of the Board, HanchorBio

Director of the Board, HanchorBio

AUDREY TSENG, M.B.A.

AUDREY TSENG, M.B.A.

Director of the Board

Director of the Board